These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7301637)

  • 1. Behavioral effects of dynorphin 1-13 in the mouse and rat: initial observations.
    Walker JM; Katz RJ; Akil H
    Peptides; 1980; 1(4):341-5. PubMed ID: 7301637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin-(1-13) induces spontaneous feeding in rats.
    Morley JE; Levine AS
    Life Sci; 1981 Nov; 29(18):1901-3. PubMed ID: 7311723
    [No Abstract]   [Full Text] [Related]  

  • 3. Peptide-induced excessive grooming in the rat: the role of opiate receptors.
    Aloyo VJ; Spruijt B; Zwiers H; Gispen WH
    Peptides; 1983; 4(6):833-6. PubMed ID: 6324139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone reserves the inhibitory effects of dynorphin A on motor activity in the mouse.
    Ukai M; Yamada S; Kameyama T
    Pharmacol Biochem Behav; 1984 May; 20(5):815-8. PubMed ID: 6146145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antagonistic effects of naloxone on hypermotility in mice induced by dynorphin-(1-13) using a multi-dimensional behavioral analysis.
    Ukai M; Kameyama T
    Neuropharmacology; 1984 Feb; 23(2A):165-8. PubMed ID: 6717756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neurochemical effects of the new opioid peptide dynorphin--(1-13): comparison with other neuropeptides.
    Zwiers H; Aloyo VJ; Gispen WH
    Life Sci; 1981 Jun; 28(22):2545-51. PubMed ID: 6265732
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrophysiological evidence for kappa-agonist activity of dynorphin in rat brain.
    Brookes A; Bradley PB
    Neuropharmacology; 1984 Feb; 23(2A):207-10. PubMed ID: 6325991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
    Faden AI; Jacobs TP
    Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects and in vivo degradation of intraventricularly administered dynorphin-(1-13) and D-Ala2-dynorphin-(1-11) in rats.
    Herman BH; Leslie F; Goldstein A
    Life Sci; 1980 Sep; 27(10):883-92. PubMed ID: 7191035
    [No Abstract]   [Full Text] [Related]  

  • 10. Dynorphin-(1-13), dopamine and feeding in rats.
    Morley JE; Levine AS; Grace M; Kneip J
    Pharmacol Biochem Behav; 1982 May; 16(5):701-5. PubMed ID: 6283566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive effect of dynorphin-(1-13) on luteinizing hormone release in conscious castrated rats.
    Kinoshita F; Nakai Y; Katakami H; Imura H
    Life Sci; 1982 May; 30(22):1915-9. PubMed ID: 6287134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
    Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intracerebroventricular injection of dynorphin, leumorphin and alpha neo-endorphin on operant feeding in pigs.
    Baldwin BA; de la Riva C; Ebenezer IS
    Physiol Behav; 1990 Dec; 48(6):821-4. PubMed ID: 1982360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects of dynorphin -- a novel opioid neuropeptide.
    Katz RJ
    Neuropharmacology; 1980 Aug; 19(8):801-3. PubMed ID: 6106908
    [No Abstract]   [Full Text] [Related]  

  • 15. Dynorphin: potent analgesic effect in spinal cord of the rat.
    Han JS; Xie CW
    Sci Sin B; 1984 Feb; 27(2):169-77. PubMed ID: 6147015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-selective opioid peptides fail to affect behavioral responses induced by a low dose of apomorphine in the mouse.
    Ukai M; Toyoshi T; Kameyama T
    Pharmacol Biochem Behav; 1993 Nov; 46(3):587-91. PubMed ID: 7904071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of dynorphin and the kappa opioid receptor in feeding.
    Morley JE; Levine AS
    Peptides; 1983; 4(6):797-800. PubMed ID: 6143298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin A: inhibitory effect on other opiate ligand bindings in the mouse brain.
    Garzón J; Sánchez-Blázquez P; Gerhart J; Loh HH; Lee NM
    Biochem Pharmacol; 1984 Aug; 33(16):2609-14. PubMed ID: 6147144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
    Huidobro-Toro JP; Zhu YX; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1984 Feb; 228(2):293-303. PubMed ID: 6141281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.